MetaStat (OTC:MTST) said this week that it closed the 1st tranche of a $7 million private placement.
The round, which was led by Perceptive Advisors, is slated to bring in approximately $2.1 million, according to the Boston-based company.
Get the full story at our sister site, Drug Delivery Business News.
The post MetaStat lands $7m for personalized cancer diagnostic, therapy tech appeared first on MassDevice.